Recombinant antigen B13 for Trypanosoma cruzi

Trypanosoma cruzi

B13 protein is an immunodominant recombinant antigen which encodes part of the tandemly repeated domain of the Trypanosoma cruzi. It is a 140/116 kDa protein located on the surface of infective trypomastigotes from several strains.

Recombinant antigen for the diagnosis of Chagas caused by Trypanosoma cruzi, a human and animal infectious disease (mainly dogs).

or
Name
B13
Description
CA-2 surface antigen. Also known as Ag2, PEP2, TcR34
Gene
B13
Purity
> 95% by observation on SDS-PAGE electrophoresis
Cat number
SKU Source Applications In-house validation Details
RAG0103 E. coli WB, DB, IE, DE, CLIA, LF ELISA Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk
* under availability, for liquid format
Related proteins
1F8 ChimChagas1 ChimChagas2 ChimChagas3 FRA
Related antibodies

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Recombinant antigens for infectious diseases

How to reconsitute lyophizated vials

Recombinant antigens for the diagnosis of Chagas